Unbiased Analysis of Today's Healthcare Issues

Highlights from the 2017 ISPOR Conference

Over the past few days, I have been attending the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2017 Annual Conference in Boston. The session had a number of interesting presentations. While I was not able to catch them all, below are links to a few highlights. Darius Lakdawalla, Defining and Measuring Value in Healthcare […]

Read the rest of this entry »

Need health care data?

The International Society For Pharmacoeconomics and Outcomes Research (ISPOR) has put together a database of databases from around the world. The ISPOR International Digest of Databases has goal is to organize global health care databases into searchable models.  Their working group on this topic is chaired by Carl Asche and Elisabeth Oehrlein.  If you have […]

Read the rest of this entry »

Should cost-effectiveness analysis ignore the price of the drug?

Cost effectiveness analysis (CEA) aims to examine whether the benefits of a treatment outweigh the costs.  However, whenever one is conducting a CEA a key question is benefits to whom and costs to whom.  For instance, a modestly efficacious  drug may be cost effective from the patient’s perspective if all or most costs are covered by insurance. […]

Read the rest of this entry »